0001209191-23-043525.txt : 20230727 0001209191-23-043525.hdr.sgml : 20230727 20230727162136 ACCESSION NUMBER: 0001209191-23-043525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jerel Davis CENTRAL INDEX KEY: 0001745958 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231118713 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turnstone Biologics Corp. CENTRAL INDEX KEY: 0001764974 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832909368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 347-897-5988 MAIL ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-25 0 0001764974 Turnstone Biologics Corp. TSBX 0001745958 Jerel Davis C/O TURNSTONE BIOLOGICS CORP. 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 1 0 1 0 0 Common Stock 2023-07-25 4 C 0 2528864 A 2528864 I By Versant Venture Capital V, L.P. Common Stock 2023-07-25 4 C 0 192458 A 192458 I By Versant Venture Capital V (Canada) LP Common Stock 2023-07-25 4 C 0 84313 A 84313 I By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock 2023-07-25 4 C 0 76067 A 76067 I By Versant Affiliates Fund V, L.P. Common Stock 2023-07-25 4 C 0 274990 A 274990 I By Versant Vantage II, L.P. Common Stock 2023-07-25 4 P 0 197458 12.00 A 2726322 I By Versant Venture Capital V, L.P. Common Stock 2023-07-25 4 P 0 15028 12.00 A 207486 I By Versant Venture Capital V (Canada) LP Common Stock 2023-07-25 4 P 0 6575 12.00 A 90888 I By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock 2023-07-25 4 P 0 5939 12.00 A 82006 I By Versant Affiliates Fund V, L.P. Series A Preferred Stock 2023-07-25 4 C 0 7897999 0.00 D Common Stock 988832 0 I By Versant Venture Capital V, L.P. Series A Preferred Stock 2023-07-25 4 C 0 601077 0.00 D Common Stock 75255 0 I By Versant Venture Capital V (Canada) LP Series A Preferred Stock 2023-07-25 4 C 0 263349 0.00 D Common Stock 32971 0 I By Versant Ophthalmic Affiliates Fund I, L.P. Series A Preferred Stock 2023-07-25 4 C 0 237575 0.00 D Common Stock 29744 0 I By Versant Affiliates Fund V, L.P. Series B-1 Preferred Stock 2023-07-25 4 C 0 3530789 0.00 D Common Stock 442055 0 I By Versant Venture Capital V, L.P. Series B-1 Preferred Stock 2023-07-25 4 C 0 268711 0.00 D Common Stock 33642 0 I By Versant Venture Capital V (Canada) LP Series B-1 Preferred Stock 2023-07-25 4 C 0 117730 0.00 D Common Stock 14739 0 I By Versant Ophthalmic Affiliates Fund I, L.P. Series B-1 Preferred Stock 2023-07-25 4 C 0 106208 0.00 D Common Stock 13297 0 I By Versant Affiliates Fund V, L.P. Series B-2 Preferred Stock 2023-07-25 4 C 0 7650043 0.00 D Common Stock 957787 0 I By Versant Venture Capital V, L.P. Series B-2 Preferred Stock 2023-07-25 4 C 0 582206 0.00 D Common Stock 72892 0 I By Versant Venture Capital V (Canada) LP Series B-2 Preferred Stock 2023-07-25 4 C 0 255081 0.00 D Common Stock 31936 0 I By Versant Ophthalmic Affiliates Fund I, L.P. Series B-2 Preferred Stock 2023-07-25 4 C 0 230117 0.00 D Common Stock 28810 0 I By Versant Affiliates Fund V, L.P. Series C Preferred Stock 2023-07-25 4 C 0 1119729 0.00 D Common Stock 140190 0 I By Versant Venture Capital V, L.P. Series C Preferred Stock 2023-07-25 4 C 0 85217 0.00 D Common Stock 10669 0 I By Versant Venture Capital V (Canada) LP Series C Preferred Stock 2023-07-25 4 C 0 37283 0.00 D Common Stock 4667 0 I By Versant Ophthalmic Affiliates Fund I, L.P. Series C Preferred Stock 2023-07-25 4 C 0 33682 0.00 D Common Stock 4216 0 I By Versant Affiliates Fund V, L.P. Series D Preferred Stock 2023-07-25 4 C 0 2196402 0.00 D Common Stock 274990 0 I By Versant Vantage II, L.P. Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date. Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. The Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of his respective pecuniary interest therein. Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. The Reporting Person, a member of the Issuer's board of directors, is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein. Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. The Reporting Person disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of his respective pecuniary interest therein. Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. The Reporting Person disclaims beneficial ownership of the shares held by Affiliates, except to the extent of his respective pecuniary interest therein. Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP") is the sole general partner of Vantage II GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein. /s/ P. Joseph Campisi, Jr., Attorney-in-Fact 2023-07-27